|
|
|
|
| LEADER |
03342nam a2200529 4500 |
| 001 |
ocn973396828 |
| 003 |
OCoLC |
| 005 |
20180501122035.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
170222s2017 maua o 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d OPELS
|d IDEBK
|d EBLCP
|d N$T
|d YDX
|d OCLCF
|d OCLCQ
|d MEU
|d GrThAP
|
| 066 |
|
|
|c (S
|
| 019 |
|
|
|a 973506691
|a 973755068
|a 973798715
|a 973907039
|a 974033102
|a 1028922417
|a 1030785129
|
| 020 |
|
|
|a 9780128123911
|q (electronic bk.)
|
| 020 |
|
|
|a 0128123915
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128123904
|q (print)
|
| 020 |
|
|
|a 0128123907
|
| 035 |
|
|
|a (OCoLC)973396828
|z (OCoLC)973506691
|z (OCoLC)973755068
|z (OCoLC)973798715
|z (OCoLC)973907039
|z (OCoLC)974033102
|z (OCoLC)1028922417
|z (OCoLC)1030785129
|
| 050 |
|
4 |
|a QH599
|b .C47 2017eb
|
| 072 |
|
7 |
|a SCI
|x 007000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI
|2 ukslc
|
| 082 |
0 |
4 |
|a 572.8/7
|2 23
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Chromatin Proteins and Transcription Factors as Therapeutic Targets /
|c edited by Rossen Donev.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Academic Press is an imprint of Elsevier,
|c 2017.
|
| 300 |
|
|
|a 1 online resource (xvi, 369 pages :
|b color illustrations).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in protein chemistry and structural biology ;
|v volume 107
|
| 546 |
|
|
|a Text in English.
|
| 500 |
|
|
|a Includes indexes.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed February 24, 2017).
|
| 505 |
8 |
|
|a 2.2.1. Posttranslational Acetylation2.2.2. Oxidation; 2.3. HMGB1-Receptor Families; 2.3.1. Receptor for Advanced Glycation End Products; 2.3.2. Toll-Like Receptors; 2.3.3. Recently Discovered HMGB1 Receptors; 3. HMGB1 in the Nucleus-An Architectural Factor; 3.1. Nucleolar Functions; 3.1.1. DNA Replication, Repair, and V(D)J Recombination; 3.1.2. Gene Transcription Transfer and Delivery; 3.1.3. Nucleosome Structure and Dynamics; 3.1.4. Telomere Homeostasis; 3.2. HMGB1 as a Damage Recognition Protein Mediating the Antitumor Effect of the Chemotherapeutic Drug cis-Platin
|
| 505 |
8 |
|
|a 3.3. HMGB1 Protein-An Important Player in cis-platin-Based Therapy3.3.1. HMGB1 Affects the Repair of DNA Damaged by the Antitumor Drug cis-Platin In Vitro; 3.3.2. The Impact of HMGB1 Protein for the Repair Potential of Human Cancer Cell Lines: A Significant Issue for Therapeut ...; 4. HMGB1 Outside the Cell; 4.1. HMGB1 as a Signaling Molecule; 4.2. HMGB1 and Diseases; 5. HMGB1 as a Therapeutic Target; 5.1. Antibody-Based Targeting; 5.2. Peptides and Protein Inhibitors of HMGB1; 5.3. Blockage of HMGB1-Receptor Signaling; 5.4. Small Molecules Inhibiting HMGB1
|
| 504 |
|
|
|a Includes bibliographical references and indexes.
|
| 650 |
|
0 |
|a Chromatin.
|
| 650 |
|
0 |
|a Transcription factors.
|
| 650 |
|
7 |
|a SCIENCE / Life Sciences / Biochemistry
|2 bisacsh
|
| 650 |
|
7 |
|a Chromatin.
|2 fast
|0 (OCoLC)fst00859922
|
| 650 |
|
7 |
|a Transcription factors.
|2 fast
|0 (OCoLC)fst01154564
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Donev, Rossen,
|e editor.
|
| 776 |
0 |
8 |
|c Original
|z 0128123907
|z 9780128123904
|w (OCoLC)959869209
|
| 830 |
|
0 |
|a Advances in protein chemistry and structural biology ;
|v v. 107.
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/18761623/107
|z Full Text via HEAL-Link
|